Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary
Authors
Benjamin Li (ORCID: https://orcid.org/0000-0002-1783-7013)
Lynn McRoy
Adam Brufsky (ORCID: https://orcid.org/0000-0001-8080-7960)
Rachel M. Layman (ORCID: https://orcid.org/0000-0002-8663-0331)
Hope S. Rugo (ORCID: https://orcid.org/0000-0001-6710-4814)
Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary
Benjamin Li, Lynn McRoy, Adam Brufsky, Rachel M. Layman et al.
Local Database Links
3 links
Journal
Future Oncology
Topics
Advanced Breast Cancer Therapies
article
Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary
Benjamin Li, Lynn McRoy, Adam Brufsky, Rachel M. Layman, Hope S. Rugo, Connie Chen, Xianchen Liu
article en
Abstract
No abstract available for this paper.
Publication Tag
Future OncologyVol. 21(11)
Institutions
The University of Texas MD Anderson Cancer Center (US), University of California, San Francisco (US), Pfizer (United States) (US), UPMC Hillman Cancer Center (US), University of Pittsburgh Medical Center (US), UCSF Helen Diller Family Comprehensive Cancer Center (US)